Bovie pulls SEER and BOSS off market with Medtronic/Salient settlement
This article was originally published in Clinica
Executive Summary
Bovie Medical is to stop selling immediately its SEER and BOSS monopolar and bipolar saline-enhanced radiofrequency devices worldwide as part of a patent dispute settlement with Salient Surgical Technologies and Medtronic.